Gastric metastases from accessory breast cancer

Kimura, Hiroyuki; Kinoshita, Seiichi; Takahashi, Ikuo

doi:10.1067/mge.2002.127150

Cited by 4 publications

(5 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Metastatic gastric tumors may originate from various organs [9, 10, 11, 12, 13, 14, 15, 16, 17] but are most common from breast, lung, and esophageal cancers and melanoma [4, 5]. Oda et al reported that malignant melanoma was the most common tumor to metastasize to the stomach [5].…”

Section: Discussionmentioning

confidence: 99%

“…Surgical resection is recommended to improve the patients' quality of life or for selected tumors such as melanoma. [11] Ovary Debulking/CX Gastrectomy Peritoneum 6 months Miyashita [12] Appendix Debulking EMR None > 3 years Okabayashi [13] Chest wall Resection Gastrectomy Chest wall 40 days Aydiner [15] Testis CX/RT/resection Gastrectomy Lung, liver, adrenal gland, brain > 7 months Kimura [16] Accessory breast Resection CX Lung Not stated Basu [25] Breast Resection CX Colon > 38 months Pector [31] Malignant melanoma Resection/CX Gastrectomy None 6 years Suzaki [32] Lung Resection/CX CX None 13 days Kishino [33] Esophagus Resection Resection b Liver 110 days Jeladharan [34] Uterus RT Gastrectomy None Not stated Wu [35] Hypopharynx Resumen. La caracterı ´stica clı ´nica del tumor ga ´strico metasta ´sico (TGM) no ha sido bien documentada.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Clinical Diagnosis of Metastatic Gastric Tumors: Clinicopathologic Findings and Prognosis of Nine Patients in a Single Cancer Center

et al. 2004

View full text Add to dashboard Cite

The clinical features of metastatic gastric tumors (MGTs) have not been well documented. We present a clinical series of nine patients with MGTs. Among 2579 patients with gastric tumors seen between 1992 and 2001, we studied 9 (0.3%) patients with MGT according to a prospective database. The MGTs were diagnosed based on findings in the surgical or endoscopic specimen, and patients with malignant lymphoma or direct invasion from adjacent organs were excluded from the study. MGTs were detected simultaneously with the primary tumors in three and afterward in six patients at 14 to 74 months. The primary tumors included one each of squamous cell carcinoma of the esophagus, signet-ring cell carcinoma of the breast, large-cell or small-cell carcinoma of the lung, renal cell carcinoma, hepatocellular carcinoma, squamous cell or epidermoid carcinoma of the uterus, and melanoma. Multiple organ metastases were present simultaneously in six patients. Although six patients underwent gastrectomy, macroscopic eradication of gastric metastatic disease was accomplished in only four, in whom a UICC R0 resection was possible in only two. Five patients were treated by chemotherapy with no apparent survival benefit. A median survival after MGT diagnosis was 170 days (range 16-892 days) for all cases, 384 days for those who underwent gastrectomy (n = 6), and 27 days for those without active treatment (n = 3) (p = 0.002). The cause of death was multiple organ metastases in most cases. Because multiple metastases are common, the prognosis of MGT is poor even after curative resection. MGT is likely to be a preterminal event, and surgical resection may be useful only for palliation.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Clinical Diagnosis of Metastatic Gastric Tumors: Clinicopathologic Findings and Prognosis of Nine Patients in a Single Cancer Center

et al. 2004

View full text Add to dashboard Cite

show abstract

“…The third possible explanation for such a perceived paucity of literature‐cited examples of GIT metastasis management is that the major tool for diagnosing GIT lesions would appear to have progressively changed over the last couple of decades. Those available larger case studies reported in the literature focusing on a discussion of metastatic tumors of the GIT that we were able to review were mostly examples of a diagnosis performed by autopsy, surgical intervention and/or radiology, 3,5 , 6,8 , 9 there being only a few case reports available that were described from the view of endoscopists 10–15 …”

Section: Introductionmentioning

confidence: 99%

Incidence, endoscopic morphology and distribution of metastatic lesions in the gastrointestinal tract

Wei

Chang

et al. 2006

J of Gastro and Hepatol

View full text Add to dashboard Cite

show abstract

“…Currently, the most affected sites in the female population are the bones, lungs, liver, and soft tissue [2] . The incidence of GM is low in studies of general populations, reaching 8.9% among all metastasis sites originating from breast cancer [6] . However, due to the rarity of the relationship between breast cancer and its metastasis in male patients, this association was observed in only two cases.…”

Section: Discussionmentioning

confidence: 91%

Gastric metastasis from breast cancer in male patient - Case report and literature review

Cardoso

Dias

Cohen³

et al. 2021

International Journal of Surgery Case Reports

View full text Add to dashboard Cite

Introduction Male breast cancer has a low incidence, and its metastases are considered even rarer and a sign of seriousness for the patient. Breast metastases are difficult to diagnose even in female patients, with few cases of gastric metastasis described in the current literature. Presentation of case Male patient, 54 years old, obese, diagnosed with breast cancer for 8 years, underwent 5 years of cancer follow-up. After this period, he began to experience epigastric pain and weight loss, among other symptoms. Endoscopy was performed, showing rounded elevated lesions with central depression. After anatomopathological and biochemical tests, a diagnosis of differentiated carcinoma as a metastasis of breast origin was concluded. Discussion MBC is rare when compared to the incidence in females. Its risk factors differ between genders, and due to its rarity, there are few studies in the male population. This fact makes the evaluation of metastases more difficult. Gastric metastasis has a very low incidence even in women, approximately 8.9% of all breast cancer metastasis's locations. Other pathologies can mimic GM, always associating anatomopathological and biochemical tests. Oncological follow-up must always be carried out, and the possibility of screening must be evaluated. Conclusion Despite the rare incidence and little information in the literature, the association between MBC and GM should be considered. Currently, there is no guidance for conducting systematic screenings and treatment is usually palliative due to the severity of the disease.

show abstract

Gastric metastases from accessory breast cancer

Cited by 4 publications

References 0 publications

Clinical Diagnosis of Metastatic Gastric Tumors: Clinicopathologic Findings and Prognosis of Nine Patients in a Single Cancer Center

Clinical Diagnosis of Metastatic Gastric Tumors: Clinicopathologic Findings and Prognosis of Nine Patients in a Single Cancer Center

Incidence, endoscopic morphology and distribution of metastatic lesions in the gastrointestinal tract

Gastric metastasis from breast cancer in male patient - Case report and literature review

Contact Info

Product

Resources

About